Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

NCT07699770 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorders (NMOSD)
Neuropathic Pain

Interventions

DRUG: Crisugabalin
DRUG: Placebo+Crisugabalin

Sponsor

Tang-Du Hospital